3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pain, Intractable
1
Pain
1
Neoplasms
1
Bone Neoplasms
1
Interventions
Ibandronic Acid
8
Zoledronic Acid
5
Irinotecan
3
Temozolomide
2
Radiation
2
Doxorubicin
2
Denosumab
2
Cyclophosphamide
2
Cryotherapy
2
Cryosurgery
2
selinexor
1
saracatinib
1
robatumumab
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
palbociclib
1
liposomal doxorubicin
1
cc-486
1
anlotinib
1
Vincristine
1
Topotecan
1
Taxes
1
Radiotherapy
1
Quality of Life
1
Pregabalin
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Observation
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Bone Neoplasms
×
Pregabalin
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts